Research Analysts Issue Forecasts for USPH Q1 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - William Blair dropped their Q1 2025 earnings per share (EPS) estimates for U.S. Physical Therapy in a note issued to investors on Tuesday, March 11th. William Blair analyst J. Haase now forecasts that the company will post earnings of $0.48 per share for the quarter, down from their prior forecast of $0.56. William Blair has a "Market Perform" rating on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy's Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.77 EPS, Q4 2025 earnings at $0.76 EPS, FY2025 earnings at $2.73 EPS and FY2026 earnings at $3.05 EPS.

USPH has been the topic of a number of other reports. StockNews.com lowered shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday, February 28th. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Barrington Research reduced their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. JPMorgan Chase & Co. boosted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Tuesday, December 3rd. Finally, JMP Securities assumed coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $111.50.

Remove Ads

U.S. Physical Therapy Trading Down 0.1 %

Shares of USPH stock traded down $0.07 during mid-day trading on Thursday, reaching $76.42. 97,553 shares of the stock traded hands, compared to its average volume of 98,496. The stock's fifty day simple moving average is $86.17 and its two-hundred day simple moving average is $87.37. U.S. Physical Therapy has a 1-year low of $76.05 and a 1-year high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.16 billion, a price-to-earnings ratio of 81.30, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.36%. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy's dividend payout ratio is presently 97.83%.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in U.S. Physical Therapy by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company's stock valued at $96,179,000 after buying an additional 6,393 shares during the last quarter. Copeland Capital Management LLC increased its position in shares of U.S. Physical Therapy by 9.5% during the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after acquiring an additional 72,715 shares during the last quarter. State Street Corp boosted its position in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after purchasing an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC grew its stake in U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock valued at $50,725,000 after purchasing an additional 24,698 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of U.S. Physical Therapy by 1.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock valued at $37,818,000 after purchasing an additional 7,890 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.